NCT07383415 (PRP-I RCT) is a NA clinical trial of Intranasal PRP Plus Topical Insulin in Anosmia, sponsored by Amin Javer.

Who is sponsoring NCT07383415?

NCT07383415 is sponsored by Amin Javer.

What drugs are being tested in NCT07383415?

Interventions in NCT07383415: Intranasal PRP Plus Topical Insulin, Intranasal PRP Plus Saline (Placebo).

What condition does NCT07383415 study?

NCT07383415 studies Anosmia, Inflammatory Anosmia.

Is NCT07383415 still recruiting?

NCT07383415 is currently not yet recruiting. Last updated 3 February 2026.

Last reviewed 2026-02-03 · How we verify

NCT07383415: PRP-I RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia

Not yet recruiting NA Last updated 3 February 2026

What this trial tests

NA trial testing Intranasal PRP Plus Topical Insulin in Anosmia in 20 participants. Not yet recruiting.

Timeline

30 March 2026

Primary endpoint
30 December 2026

1 January 2027

Quick facts

Lead sponsor	Amin Javer
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	30 March 2026
Primary completion	30 December 2026
Estimated completion	1 January 2027

Drugs / interventions tested

Intranasal PRP Plus Topical Insulin — full drug profile →
Intranasal PRP Plus Saline (Placebo) — full drug profile →

Conditions studied

Anosmia — all drugs for Anosmia →
Inflammatory Anosmia — all drugs for Inflammatory Anosmia →

Sponsor

Amin Javer — full company profile →

Who can join

19 and older, any sex, with Anosmia or Inflammatory Anosmia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates whether adding topical insulin to intranasal platelet-rich plasma (PRP) improves smell recovery in adults with post-inflammatory anosmia. Participants will be randomly assigned to receive either intranasal PRP combined with topical insulin or intranasal PRP alone. Changes in olfactory function will be assessed over time to compare the effectiveness and safety of the two treatments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anosmia

Currently open trials in the same condition.

NCT06733636 — Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults · NA · recruiting
NCT05562050 — Characteristics of the Anosmic Olfactory Mucosa · active not recruiting
NCT05040659 — Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2 · active not recruiting
NCT05364125 — Olfactory Training on Smell Dysfunction Patients in HK · NA · recruiting
NCT06423495 — Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19 · NA · recruiting

Other Amin Javer trials

Trials by the same sponsor.

NCT07383402 — Intra-Sinus Povidone-Iodine and Budesonide After Endoscopic Sinus Surgery for Chronic Rhinosinusitis · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07383415 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Amin Javer
Last refreshed: 3 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07383415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing